OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers
Shu Zhang, Chuan Yi, Weiwei Li, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 8
Closed Access | Times Cited: 14
Shu Zhang, Chuan Yi, Weiwei Li, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 8
Closed Access | Times Cited: 14
Showing 14 citing articles:
Ferrocene-Based Drugs, Delivery Nanomaterials and Fenton Mechanism: State of the Art, Recent Developments and Prospects
Cátia Ornelas, Didier Astruc
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 40
Cátia Ornelas, Didier Astruc
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2044-2044
Open Access | Times Cited: 40
Modern Trends in Bio-Organometallic Ferrocene Chemistry
L. V. Snegur
Inorganics (2022) Vol. 10, Iss. 12, pp. 226-226
Open Access | Times Cited: 28
L. V. Snegur
Inorganics (2022) Vol. 10, Iss. 12, pp. 226-226
Open Access | Times Cited: 28
Design, synthesis and anti-breast cancer properties of butyric ester tethered dihydroartemisinin-isatin hybrids
Shijia Zhao, Xiaoyan Zhang, Min Tang, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 705-712
Open Access | Times Cited: 7
Shijia Zhao, Xiaoyan Zhang, Min Tang, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 705-712
Open Access | Times Cited: 7
Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer
Qunfa Huang, Yanhong Li, Zeng-Jin Huang, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 284-293
Closed Access | Times Cited: 6
Qunfa Huang, Yanhong Li, Zeng-Jin Huang, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 284-293
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids as Potent Anti‐Breast Cancer Agents
Zhi Xu, Xiaoyan Zhang, Jie Liu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 3
Closed Access | Times Cited: 4
Zhi Xu, Xiaoyan Zhang, Jie Liu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 3
Closed Access | Times Cited: 4
11-Azaartemisninin derivatives bearing halogenated aromatic moieties: Potent anticancer agents with high tumor selectivity
Dung T. Nguyen, Thuong Hanh Ngo, Mai Thanh Tran, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 129969-129969
Closed Access | Times Cited: 1
Dung T. Nguyen, Thuong Hanh Ngo, Mai Thanh Tran, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 129969-129969
Closed Access | Times Cited: 1
The anti‐breast cancer potential of indole/isatin hybrids
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 3
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 3
Artemisinin‐isatin hybrids tethered via ethylene linker and their anti‐lung cancer activity
Ruo Wang, Qianru Zhang, Min Chen
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 5
Ruo Wang, Qianru Zhang, Min Chen
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 5
Two-carbon tethered artemisinin–isatin hybrids: design, synthesis, anti-breast cancer potential, and in silico study
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents
Zhi Xu, Bowen Pan, Linzhi Chen, et al.
Fitoterapia (2023) Vol. 166, pp. 105436-105436
Closed Access | Times Cited: 2
Zhi Xu, Bowen Pan, Linzhi Chen, et al.
Fitoterapia (2023) Vol. 166, pp. 105436-105436
Closed Access | Times Cited: 2
Novel ester tethered dihydroartemisinin‐3‐(oxime/thiosemicarbazide)isatin hybrids as potential anti‐breast cancer agents: Synthesis, in vitro cytotoxicity and structure–activity relationship
Shaohuan Liu, Shu Wang, Dan Xu, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1175-1182
Closed Access | Times Cited: 2
Shaohuan Liu, Shu Wang, Dan Xu, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1175-1182
Closed Access | Times Cited: 2
Dihydroartemisinin-Chloro/Bromoisatin Hybrids: Design, Synthesis, and Anti-Breast Cancer Evaluation
Ming Ma, Xin Yang, Zhen Xu
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 3, pp. 652-659
Closed Access
Ming Ma, Xin Yang, Zhen Xu
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 3, pp. 652-659
Closed Access
Heterodimeric Diketopiperazine Alkaloids from Penicillium expansum MA147 and Their Cytotoxicity
Jing Li, Jing Wang, Xi Zhou, et al.
Organic & Biomolecular Chemistry (2024)
Closed Access
Jing Li, Jing Wang, Xi Zhou, et al.
Organic & Biomolecular Chemistry (2024)
Closed Access
Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity
Peng Wang, Zhe Zhang, Wei Cao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
Peng Wang, Zhe Zhang, Wei Cao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access
